Human IFN-γ T cell ELISPOT antibody pair - 10-plate

SKU
CT640-10
Validated ELISPOT antibody pair; reagents available separately (960 determinations).
Format
10-plate
Price
€ 655
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
B Brooks-Worrell Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls Diabetes Metab Res Rev 2011 27 737-45
P Eerligh Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes Genes Immun 2011 12 415-27
Sefina Arif Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death Diabetes 2011 60 2112-9
Emanuela Martinuzzi acDCs enhance human antigen-specific T-cell responses Blood 2011 118 2128-37
M Hemmati Expression and Purification of Recombinant Mycobacterium Tuberculosis (TB) Antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and Their Diagnosis Potential for Detection of TB Patients Iran Red Crescent Med J 2011 13 556-63
Jun Li Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection Virol J 2011 8 199
Chao Zheng Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese Diabetes Metab Res Rev 2011 27 70-8
R Mallone Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society Clin Exp Immunol 2011 163 33-49
Stina Axelsson Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes PLoS One 2011 6 e29008
Ozlem Tapirdamaz Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay PLoS One 2010 5 e14452